Trial Profile
A pilot study of the use of oral modafinil added to standard care in hypercapnic respiratory failure in COPD
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2022
Price :
$35
*
At a glance
- Drugs Modafinil (Primary)
- Indications Chronic obstructive pulmonary disease; Respiratory insufficiency
- Focus Proof of concept; Therapeutic Use
- Acronyms MICOPD
- 18 Feb 2022 Status changed from completed to discontinued.
- 01 Jul 2021 Status changed from recruiting to completed.
- 19 Mar 2020 Planned End Date changed from 16 Feb 2021 to 30 Jun 2021.